Zusammenfassung
Das Innenohr ist in der Hals-Nasen-Ohren-Heilkunde wohl das wichtigste Ziel, bei dem die Gen- und Stammzelltherapie zukünftig ein Teil innovativer Behandlungsstrategien werden können. Die Schallempfindungsschwerhörigkeit ist, war und wird eine große therapeutische Herausforderung sein. Das gegenwärtige Management ist nicht kausal orientiert. Seit den ersten Versuchen 1994 durch Fujiyoshi, eine genbasierte, spezifisch auf das Innenohr abzielende Therapie zu entwickeln, sind einige weitere Erkenntnisse gesammelt worden. Im Labor wurden Fortschritte im Bereich der Genetik, des Verständnisses molekularer Signalwege, der Haarzellentwicklung und -regeneration und der Stammzellbiologie erzielt. Dadurch wurde auch die mögliche Rolle dieser zellulären und intrazellulären Werkzeuge für eine anwendbare Lösung zur Behandlung von Innenohrerkrankungen in der Zukunft erkennbar. Hier wird ein Überblick über den aktuellen Stand in den wesentlichen Forschungszweigen gegeben.
Abstract
Within the field of otolaryngology, the inner ear is perhaps the most important target for which stem cell and gene therapy may comprise elements of primary intervention strategies in the future. As it has done in the past, sensorineural hearing loss still represents a major therapeutic challenge—and it will continue to do so in the future. Current management strategies are not cause-orientated. Since the first experiments aimed at developing a middle ear-specific gene-based therapy by Fujiyoshi in 1994, several new discoveries have been made. In the laboratory, advances in the fields of genetics, molecular signalling, stem cell biology and hair cell development and regeneration have been made. Through these advances, the potential roll of cellular and intracellular tools for the future treatment of hearing loss has been recognized. This paper comprises a review of the current status of important areas of research.
Literatur
Ahmad S, Tang W, Chang Q et al (2007) Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci U S A 104:1337–1341
Akil O, Seal R, Burke K et al (2012) Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron 75:283–293
Albu S, Muresanu D (2012) Vestibular regeneration – experimental models and clinical implications. J Cell Mol Med 16:1970–1977
Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355
Bedrosian J, Gratton M, Brigande J et al (2006) In vivo delivery of recombinant viruses to the fetal murine cochlea: trans-duction characteristics and long-term effects on auditory function. Mol Ther 14:328–335
Bermingham N, Hassan B, Price S et al (1999) Math1: an essential gene for generation of inner ear hair cells. Science 284
Buckiova D, Ranjan S, Newman T et al (2012) Minimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membrane. Nanomedicine (Lond) 7:1339–1354
Cooper L, Chan D, Roediger F et al (2006) AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity. Otol Neurotol 27:484–490
Cox B, Luiu Z, Lagarde M et al (2012) Conditional gene expression in the mouse inner ear using Cre-loxP. J Assoc Res Otolaryngol 13:295–322
Chaikhoutdinov I, Goldenberg D (2013) Impact of genetic targets on therapy in head and neck squamous cell carcinoma. Adv Exp Med Biol 779:165–177
Dorsey K, Agulnik M (2013) Promising new molecular targeted therapies in head and neck cancer. Drugs 73:315–325
Fire A, Xu S, Montogomery M et al (1998) Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans. Nature 391:806–811
Forge A, Li L, Corwin J et al (1993) Ultrastructureal evidence for hair cell regeneration in the mammalian inner ear. Science 259:1616–1619
Fritzsch B, Pauley S, Beisel K (2006) Cells molecules and morphogenesis: the making of the vertebrate ear. Brain Res 1091:151–171
Fritzsch B, Tessarollo L, Coppola E et al (2004) Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidence. Prog Brain Res 146
Fujiyoshi T, Hood L, Yoo T (1994) Restoration of brain stem auditory-evoked potentials by gene transfer in shiverer mice. Ann Otol Rhinol Laryngol 103:449–456
Fukui H, Raphael Y (2013) Gene therapy for the inner ear. Hear Res 297:99–105
Fukui H, Wong H, Beyer L et al (2012) BDNF gene therapy induces auditory nerve survival and fiber sprouting in deaf Pou4f3 mutant mice. Sci Rep 2:838
Gaylor J, Raman G, Chung M et al (2013) Cochlear implantation in adults: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 139:262–272
Gifford R, Dorman M, Skarzynski H et al (2013) Cochlear implantation with hearing preservation yields significant benefit for speech recognition in complex listening environments. Ear Hear 34:413–425
Giraldez F, Fritzsch B (2007) The molecular biology of ear development – „twenty years are nothing“. Int J Dev Biol 51:429–438
Glueckert R, Bitsche M, Miller M et al (2008) Deafferentattion-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol 507:1602–1621
Griesenbach U, Alton E (2013) Moving forward: cystic fibrosis gene therapy. Hum Mol Genet 22:R51–R58
Han Z, Yang J, Chi F et al (2010) Survival and fate of transplanted embryonic neural stem cells by Atoh1 gene transfer in guinea pigs cochlea. Neuroreport 21:490–496
Hawkins R, Bashiardes S, Helms C et al (2003) Gene expression differences in quiescent versus regenerating hair cells of avian sensory epithelia: implications for human hearing and balance disorders. Hum Mol Genet 12:1261–1272
Hawkins R, Bashiardes S, Powder K et al (2007) Large scale gene expression profiles of regenerating inner ear sensory epithelia. PLoS One 2:e525
Hoffman T (2012) Systemic therapy strategies for head-neck carcinomas: current status. Laryngorhinootologie 91:S123–S143
Husseman J, Raphael Y (2009) Gene therapy in the inner ear using adenovirus vectors. Adv Otorhinolaryngol 66:37–51
Ito J, Kojima K, Kawaguchi S (2001) Survival of neural stem in the cochlea. Acta Otolaryngol 121:140–142
Kawamoto K, Yagi M, Stover T et al (2003) Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther 7:484–492
Li H, Liu H, Heller S (2003) Pluripotent stem cells from the adult mouse inner ear. Nat Med 9:1293–1299
Maass J, Carrasco L, Dentone L et al (2009) Genetic therapy as molecular tool for hair cell regeneration. Rev Otorrinolaringol Cir Cabeza Cuello 69:55–60
Maeda Y, Fukushima K, Nishizaki K et al (2005) In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet 14:1641–1650
Majoros I, Williams C, Tomalia D et al (2008) New dendrimers: syntesis and characterization of popam – pamam hybrid dendrimers. Macromolecules 41:8372–8379
Matsumoto M, Nakagawa T, Kojima K et al (2008) Potential of embryonic stem cell-derived neurons for synapse formation with auditory hair cells. J Neurosci Res 86:3075–3085
Nanoci (2013) Nanotechnology based cochlear implants. [Online im Internet:]. http://www.nanoci.org [Stand: 14.10.2013; 18:11 Uhr]
National Institute of Health N (1995) Cochlear implants in adults and children. NIH Consens Statement 13:1–30
Okano T, Kelley M (2012) Stem cell therapy for the inner ear: recent advances and future directions. Trends Amplif 16:4–18
Oshima K, Shin K, Diensthuber M et al (2010) Mechanosensitive hair cell-like cells from embryonic and induced pluripotent stem cells. Cell 141:704–716
Pfannenstiel S, Praetorius M (2008) Protektion und Regeneration sensorischer Epithelien des Innenohres. HNO 56:13–20
Platt M, Metson R, Stankovic K (2009) Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma. Curr Opin Allergy Clin Inmunol 9:23–28
Praetorius M, Staecker H, Plinkert P (2009) Chirurgische Techik der Kochleaimplantation. HNO 57:663–670
Ronaghi M, Nasr M, Heller S (2012) Concise review: inner ear stem cells – an oxymoron, but why? Stem Cells 30:69–74
Rubel E, Dew L, Roberson D (1995) Mammalian vestibular hair cell regeneration. Science 267:701–707
Rubel E, Fritzsch B (2002) Auditory system development: primary auditory neurons and their targets. Annu Rev Neurosci 25:51–101
Rubel E, Furrerm S, Stone J (2013) A brief history of hair cell regeneration research and speculations on the future. Hear Res 297:42–51
Schlecker C, Praetorius M, Brough D et al (2011) Selective atonal gene delivery improves balance function in a mouse model of vestibular disease. Gene Ther 18:884–890
Shi F, Edge A (2013) Prospects for replacement of auditory neurons by stem cells. Hear Res 297:106–112
Shibita S, Cortez S, Wiler J et al (2012) Hyaluronic acid enhances gene delivery into the cochlea. Hum Gene Ther 23:302–310
Staecker H, Praetorius M, Brough D (2011) Development of gene therapy for inner ear disease: using bilateral vestibular hypofunction as a vehicle for translational research. Hear Res 276:44–51
Sun H, Huan A, Cao S (2011) Current status and prospects of gene therapy for the inner ear. Hum Gene Ther 22:1311–1322
Tamura T, Kita T, Nakagawa T et al (2005) Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 115:2000–2005
Thomas S, Grandis J (2009) The current state of head and neck cancer gene therapy. Hum Gene Ther 20:1565–1575
Vickers T, Koo S, Bennet C et al (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem 278:7108–7118
Einhaltung ethischer Richtlinien
Interessenkonflikt. H.A. Breinbauer und M. Praetorius geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Breinbauer, H., Praetorius, M. Gentherapie und Stammzellen für das Innenohr. HNO 62, 93–99 (2014). https://doi.org/10.1007/s00106-013-2822-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-013-2822-0